Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 449.53
   
  • Change Today:
    $-5.14
  • 52 Week High: $513.76
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 1,295,520
  • Market Cap: $115,502m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 449.53
Change Today $ -5.14
% Change -1.13 %
52 Week High $513.76
52 Week Low $374.46
Volume 1,295,520
Shares Issued 256.94m
Market Cap $115,502m
Beta 0.01
RiskGrade 164

Trades for 14-Jan-2026

Time Volume / Share Price
15:59 180 @ $449.65
15:59 40 @ $449.64
15:59 40 @ $449.50
15:59 40 @ $449.53
15:59 40 @ $449.53

Top of Page